We are live on ! Find out more
RCEL icon

Avita Medical

62 hedge funds and large institutions have $89.6M invested in Avita Medical in 2021 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 22 increasing their positions, 16 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

38% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 16

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

3.5% less ownership

Funds ownership: 33.45% → 29.95% (-3.5%)

10% less funds holding

Funds holding: 69 → 62 (-7)

50% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 14

70% less capital inflows, than outflows

Capital inflows: $6.19M | Capital outflows: $20.4M

Holders
62
Holders Change
-7
Holders Change %
-10.14%
% of All Funds
0.95%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
7
Increased
22
Reduced
16
Closed
14
Calls
$365​K
Puts
–
Net Calls
+$365​K
Net Calls Change
+$1.69​M

RCEL Hedge Fund Activity: Q4 2021 in Review

62 of the 6,524 institutional investors tracked by Wall St. Rank reported a position in Avita Medical (RCEL) for Q4 2021, worth a combined $89.6M — down 40% from $148M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of RCEL and 7 opened new positions — a net loss of 7 holders — while 16 trimmed existing stakes and 22 added.

The largest buyer was Goldman Sachs, adding an estimated $1.08M. The largest seller was Redmile Group, cutting an estimated $10.3M.

  • 62 institutional investors held Avita Medical (RCEL) as of Q4 2021, down from 69 in Q3 2021.
  • Funds reported $89.6M of Avita Medical stock for Q4 2021, down 40% quarter-over-quarter.
  • 7 funds opened new Avita Medical positions in Q4 2021 and 14 closed out, a net change of -7 holders.
  • The largest Avita Medical buyer in Q4 2021 was Goldman Sachs, an estimated $1.08M added.
  • The largest Avita Medical seller in Q4 2021 was Redmile Group, an estimated $10.3M sold.

Based on aggregated 13F filings for Q4 2021.